Literature DB >> 22159680

Microincision vitrectomy procedure using Intrector technology.

Frank H Koch1, Michael J Koss.   

Abstract

OBJECTIVE: To describe the procedure of pars plana vitrectomy (PPV) using an instrument designed for microincision vitrectomy.
METHODS: In this retrospective, noncomparative, interventional case series, 6 different surgeons performed 4509 PPV procedures from August 1, 2005, through May 31, 2010, with 1-port vitrectomy using a miniaturized multifunction probe (the Intrector).
RESULTS: Complications were reported in 20 eyes (0.44%). Culture-positive endophthalmitis occurred in 2 eyes (0.04%), sterile endophthalmitis occurred in 6 eyes (0.13%), intraoperative or postoperative retinal detachment occurred in 4 eyes (0.09%), and vitreous hemorrhage occurred in 8 eyes (0.18%). None of the 20 eyes with complications of 4509 total eyes had worse visual outcomes than preoperative visual acuity.
CONCLUSION: One-port vitrectomy using the Intrector is a procedure that can be used efficiently for selected cases that do not require membrane peeling.

Entities:  

Mesh:

Year:  2011        PMID: 22159680     DOI: 10.1001/archophthalmol.2011.341

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  [Proteome analysis of undiluted vitreous humor in patients with branch retinal vein occlusion].

Authors:  I Dacheva; M Reich; M Nobl; K Ceglowska; J Wasiak; J Siwy; P Zürbig; H Mischak; F H J Koch; J Kopitz; F T A Kretz; T Tandogan; G U Auffarth; M J Koss
Journal:  Ophthalmologe       Date:  2018-03       Impact factor: 1.059

2.  [Intravitreal fibrinolysis and retinal vein occlusion].

Authors:  T Bertelmann; T Stief; W Sekundo; M Witteborn; S Strodthoff; S Mennel; N Nguyen; M Koss
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

3.  Portable single port 23-gauge vitrectomy in postoperative endophthalmitis.

Authors:  Fabian Höhn; Florian Ta Kretz; Saumil Sheth; S Natarajan; Pankaj Singh; Frank H Koch; Michael J Koss
Journal:  Clin Ophthalmol       Date:  2015-08-13

4.  Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration.

Authors:  Devon H Ghodasra; Ryan Fante; Thomas W Gardner; Michael Langue; Leslie M Niziol; Cagri Besirli; Steven R Cohen; Vaidehi S Dedania; Hakan Demirci; Nieraj Jain; K Thiran Jayasundera; Mark W Johnson; Partho S Kalyani; Rajesh C Rao; David N Zacks; Jeffrey M Sundstrom
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.799

5.  Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)-results from the ILUVIT study.

Authors:  Svenja K Deuchler; Ralf Schubert; Pankaj Singh; Adonis Chedid; Ninel Kenikstul; Julia Scott; Thomas Kohnen; Hanns Ackermann; Frank Koch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-03       Impact factor: 3.535

6.  Evaluation of the vitreous microbial contamination rate in office-based three-port microincision vitrectomy surgery using Retrector technology.

Authors:  Flavio A Rezende; Cynthia X Qian; Przemyslaw Sapieha
Journal:  BMC Ophthalmol       Date:  2014-05-01       Impact factor: 2.209

7.  Proteomics of vitreous humor of patients with exudative age-related macular degeneration.

Authors:  Michael Janusz Koss; Janosch Hoffmann; Nauke Nguyen; Marcel Pfister; Harald Mischak; William Mullen; Holger Husi; Robert Rejdak; Frank Koch; Joachim Jankowski; Katharina Krueger; Thomas Bertelmann; Julie Klein; Joost P Schanstra; Justyna Siwy
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.